15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 9 firms covering Orthopediatrics Corp, 8 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets span $20.00 to $35.00, a moderate spread. The average target of $26.11 sits 18% above the current $22.20. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.20 next quarter toward $-0.71 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS9 ratings
Strong Buy
Strong Buy00%
Buy889%
Hold111%
Sell00%
Strong Sell00%
Based on 9 analysts giving stock ratings to Orthopediatrics Corp.
As of Sep, 8 of 9 firms rate KIDS a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
KIDS EPS & revenue forecast
EPS · NEXT QUARTER
$-0.20
Range $-0.26 – $-0.12 · 6 analysts · -23% YoY
Next period, 6 analysts expect Orthopediatrics Corp to earn $-0.20 a share (range $-0.26 – $-0.12), versus $-0.26 a year earlier. Full-year consensus is $-1.09, growing to $-0.71 the year after.
REVENUE · NEXT QUARTER
$68.6M
Range $67.9M – $69.4M · 6 analysts · +11% YoY
Revenue is expected to reach $68.6M (range $67.9M – $69.4M), +11.4% year-over-year. Full-year consensus is $267.0M, rising to $298.8M next year.
Top analysts covering Orthopediatrics Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on KIDS.
#1
Mike Matson
Needham · Rank #210
Buy
$35.00+57.7% to target
Overall win rate
34%
+ Follow
#2
David Turkaly
JMP Securities · Rank #346
Buy
$25.00+12.6% to target
Overall win rate
33%
+ Follow
#3
Matt O'Brien
Piper Sandler · Rank #424
Buy
$25.00+12.6% to target
Overall win rate
25%
+ Follow
#4
Ryan Zimmerman
BTIG
Buy
$29.00+30.6% to target
Coverage
—
+ Follow
#5
Richard Newitter
Truist Securities
Hold
$20.00-9.9% to target
Coverage
—
+ Follow
KIDS stock forecast FAQ
What is KIDS's average 12-month price target?+
The 9 analysts with a live target average $26.11 for Orthopediatrics Corp over the next 12 months, ranging from a $35.00 high to a $20.00 low.
Is KIDS stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 9 analyst ratings, 8 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for KIDS?+
The Street-high target is $35.00 (Needham), and the Street-low is $20.00 (Truist Securities). The average of all 9 active targets is $26.11.
How many Wall Street analysts cover KIDS?+
9 analysts have an active rating on Orthopediatrics Corp, and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering KIDS?+
Among analysts who currently cover KIDS, Mike Matson of Needham has the strongest overall Quantellect track record (Rank #210). Their current call is Buy with a $35.00 target.
What is Orthopediatrics Corp's projected EPS for next quarter?+
The consensus estimate is $-0.20 per share (range $-0.26 – $-0.12) across 6 analysts. Full-year EPS is projected at $-1.09, rising to $-0.71 the following year.
How much revenue is Orthopediatrics Corp expected to report next quarter?+
Consensus revenue is $68.6M (range $67.9M – $69.4M). Full-year revenue is projected at $267.0M, growing to $298.8M next year.
Have analysts been upgrading or downgrading KIDS lately?+
As of Sep, 8 of 9 firms rate KIDS a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their KIDS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
